IL280764B2 - Chromatography method and system for determining the quantity and degree of purity of a multimeric protein - Google Patents

Chromatography method and system for determining the quantity and degree of purity of a multimeric protein

Info

Publication number
IL280764B2
IL280764B2 IL280764A IL28076421A IL280764B2 IL 280764 B2 IL280764 B2 IL 280764B2 IL 280764 A IL280764 A IL 280764A IL 28076421 A IL28076421 A IL 28076421A IL 280764 B2 IL280764 B2 IL 280764B2
Authority
IL
Israel
Prior art keywords
protein
antibody
affinity matrix
fcfc
detector
Prior art date
Application number
IL280764A
Other languages
English (en)
Hebrew (he)
Other versions
IL280764A (en
IL280764B1 (en
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of IL280764A publication Critical patent/IL280764A/en
Publication of IL280764B1 publication Critical patent/IL280764B1/en
Publication of IL280764B2 publication Critical patent/IL280764B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1864—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
    • B01D15/1871—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns placed in series
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G01N30/06—Preparation
    • G01N30/14—Preparation by elimination of some components
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/86—Signal analysis
    • G01N30/8624—Detection of slopes or peaks; baseline correction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N2030/022—Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027—Liquid chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8831—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
IL280764A 2018-08-17 2019-08-16 Chromatography method and system for determining the quantity and degree of purity of a multimeric protein IL280764B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862719323P 2018-08-17 2018-08-17
PCT/US2019/046769 WO2020037182A1 (en) 2018-08-17 2019-08-16 Method and chromatography system for determining amount and purity of a multimeric protein

Publications (3)

Publication Number Publication Date
IL280764A IL280764A (en) 2021-04-29
IL280764B1 IL280764B1 (en) 2026-01-01
IL280764B2 true IL280764B2 (en) 2026-05-01

Family

ID=67851218

Family Applications (2)

Application Number Title Priority Date Filing Date
IL280764A IL280764B2 (en) 2018-08-17 2019-08-16 Chromatography method and system for determining the quantity and degree of purity of a multimeric protein
IL325196A IL325196A (en) 2018-08-17 2019-08-16 Chromatography method and system for determining the quantity and degree of purity of a multimeric protein

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL325196A IL325196A (en) 2018-08-17 2019-08-16 Chromatography method and system for determining the quantity and degree of purity of a multimeric protein

Country Status (14)

Country Link
US (2) US12152056B2 (enExample)
EP (1) EP3837552A1 (enExample)
JP (2) JP7527273B2 (enExample)
KR (2) KR102795000B1 (enExample)
CN (2) CN118641770A (enExample)
AU (2) AU2019322895B2 (enExample)
BR (1) BR112021002724A2 (enExample)
CA (1) CA3109362A1 (enExample)
EA (1) EA202190459A1 (enExample)
IL (2) IL280764B2 (enExample)
MX (1) MX2021001915A (enExample)
MY (1) MY207066A (enExample)
SG (1) SG11202101369XA (enExample)
WO (1) WO2020037182A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202101369XA (en) * 2018-08-17 2021-03-30 Regeneron Pharma Method and chromatography system for determining amount and purity of a multimeric protein
AU2020293237A1 (en) * 2019-06-13 2022-01-06 Regeneron Pharmaceuticals, Inc. Methods for removing undesired components during multistage chromatographic processes
WO2022234412A1 (en) 2021-05-03 2022-11-10 Lupin Limited A process for purification of fc-fusion proteins
CN117761217A (zh) * 2023-12-22 2024-03-26 深圳市乐土生命科技投资有限公司 一种检测Fc轻链改造双抗或Fc融合蛋白表达量的方法
WO2026075981A1 (en) * 2024-10-01 2026-04-09 Regeneron Pharmaceuticals, Inc. Methods of analyzing heterodimeric proteins

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2500073A1 (en) * 2011-03-17 2012-09-19 ChromaCon AG Method for identification and purification of multi-specific polypeptides
WO2016018740A2 (en) * 2014-07-26 2016-02-04 Regeneron Pharmaceuticals, Inc. Purification platform for bispecific antibodies
WO2017134440A2 (en) * 2016-02-05 2017-08-10 Dr Philip C JONES Heterodimers and purification thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0826696B1 (de) 1996-09-03 2002-05-29 GSF-Forschungszentrum für Umwelt und Gesundheit GmbH Verwendung bi-und trispezifischer Antikörper zur Induktion einer Tumorimmunität
US7691645B2 (en) * 2001-01-09 2010-04-06 Agilent Technologies, Inc. Immunosubtraction method
SG149759A1 (en) * 2007-07-10 2009-02-27 Millipore Corp Media for affinity chromatography
WO2010030393A1 (en) * 2008-09-15 2010-03-18 Millipore Corporation Methods for quantifying protein leakage from protein based affinity chromatography resins
TWI507525B (zh) 2009-06-26 2015-11-11 Regeneron Pharma 具天然免疫球蛋白形式之易分離的雙專一性抗體
EP2633306B1 (en) 2010-10-27 2016-03-23 GE Healthcare Bio-Sciences AB Chromatography system with guard columns
WO2012074481A1 (en) * 2010-12-03 2012-06-07 Ge Healthcare Bio-Sciences Ab System and process for biopolymer chromatography
EP2656892A1 (en) 2012-04-23 2013-10-30 Merck Patent GmbH Chromatography method
EP2847224A4 (en) 2012-05-10 2016-04-27 Zymeworks Inc SINGLE ARM MONOVALENT ANTIBODY CONSTRUCTS AND USES THEREOF
AU2014226126B2 (en) * 2013-03-08 2019-02-14 Genzyme Corporation Continuous purification of therapeutic proteins
JP2015052533A (ja) 2013-09-06 2015-03-19 株式会社日立製作所 クロマトグラフィー装置およびクロマトグラフィー方法
AP2016009222A0 (en) 2013-11-04 2016-05-31 Glenmark Pharmaceuticals Sa Production of t cell retargeting hetero-dimeric immunoglobulins
BR112017018365A2 (pt) * 2015-03-13 2018-04-10 Bristol-Myers Squibb Company uso de lavagens alcalinas durante cromatografia para remoção de impurezas
EP3280444B1 (en) 2015-04-10 2024-05-08 Adimab, LLC Methods for purifying heterodimeric multispecific antibodies from parental homodimeric antibody species
SG11202101369XA (en) * 2018-08-17 2021-03-30 Regeneron Pharma Method and chromatography system for determining amount and purity of a multimeric protein

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2500073A1 (en) * 2011-03-17 2012-09-19 ChromaCon AG Method for identification and purification of multi-specific polypeptides
WO2016018740A2 (en) * 2014-07-26 2016-02-04 Regeneron Pharmaceuticals, Inc. Purification platform for bispecific antibodies
WO2017134440A2 (en) * 2016-02-05 2017-08-10 Dr Philip C JONES Heterodimers and purification thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANDREW D. TUSTIAN ET AL,, DEVELOPMENT OF A NOVEL AFFINITY CHROMATOGRAPHY RESIN FOR PLATFORM PURIFICATION OF BISPECIFIC ANTIBODIES WITH MODIFIED PROTEIN A BINDING AVIDITY, 8 March 2018 (2018-03-08) *
ANDREW D. TUSTIAN ET AL,, DEVELOPMENT OF PURIFICATION PROCESSES FOR FULLY HUMAN BISPECIFIC ANTIBODIES BASED UPON MODIFICATION OF PROTEIN A BINDING AVIDITY, 10 March 2016 (2016-03-10) *

Also Published As

Publication number Publication date
EA202190459A1 (ru) 2021-07-21
JP7527273B2 (ja) 2024-08-02
BR112021002724A2 (pt) 2021-07-20
US12152056B2 (en) 2024-11-26
EP3837552A1 (en) 2021-06-23
AU2019322895B2 (en) 2026-03-19
IL280764A (en) 2021-04-29
CA3109362A1 (en) 2020-02-20
MY207066A (en) 2025-01-28
CN118641770A (zh) 2024-09-13
JP2024156725A (ja) 2024-11-06
KR20250053213A (ko) 2025-04-21
JP2021534398A (ja) 2021-12-09
CN112771379B (zh) 2024-07-02
IL280764B1 (en) 2026-01-01
US20210382065A1 (en) 2021-12-09
WO2020037182A1 (en) 2020-02-20
AU2026204232A1 (en) 2026-06-18
IL325196A (en) 2026-02-01
US20200055894A1 (en) 2020-02-20
SG11202101369XA (en) 2021-03-30
AU2019322895A1 (en) 2021-03-11
KR20210045413A (ko) 2021-04-26
KR102795000B1 (ko) 2025-04-15
MX2021001915A (es) 2021-05-31
CN112771379A (zh) 2021-05-07

Similar Documents

Publication Publication Date Title
SG11202101369XA (en) Method and chromatography system for determining amount and purity of a multimeric protein
IL277194A (en) Means and methods for glycoprofiling of protein
ZA202006604B (en) Method for selection of high m6p recombinant proteins
GB201818742D0 (en) Method for detection of RNA
IL275418A (en) Methods for improved removal of impurities during protein A chromatography
GB2584251B (en) Method and system for customized content
IL282035B2 (en) Method for chromatographic purification of cannabinoids
IL280628A (en) Methods for protein resequencing
IL276102A (en) System and method for characterizing protein dimerization
SG11202103572VA (en) Mass control system for chromatography
IL291284A (en) Systems and methods for expression of proteins
SG11202102816VA (en) Simulated moving-bed type chromatographic separation method and simulated moving-bed type chromatographic separation system
SG11202112352TA (en) Expression of antigen-binding proteins in the nervous system
GB201703416D0 (en) Method for protein expression
HK40046115A (en) Method and chromatography system for determining amount and purity of a multimeric protein
IL238101A (en) Method for making n - noble peptides, polypeptides and proteins
EP3628681A4 (en) METHODS TO EXTEND THE HALF-LIFE OF PROTEIN
IL310595A (en) A standard for determining the glycan profile of proteins
SG11202101900PA (en) Inducible expression system for plasmid-free production of a protein of interest
ZA202004019B (en) Method for preparing natural l-cysteine crystals by continuous chromatography
GB201919461D0 (en) Protein separation
GB201906595D0 (en) Method for purification of plasma proteins
PL3537654T3 (pl) Sposób i układ do określania konfiguracji interfejsu
HK40046595A (en) Method and system for controlling preparative liquid chromatography
HK40039534A (en) Methods for enhanced removal of impurities during protein a chromatography